AVITA Medical, Inc. (RCEL) Change in Accured Expenses (2019 - 2025)

AVITA Medical (RCEL) has reported Change in Accured Expenses for 7 consecutive years, with $7.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Change in Accured Expenses rose 996.44% year-over-year to $7.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (up 10.73% YoY), and the FY2025 full-year result was $2.7 million, up 10.73% from the prior year.
• Change in Accured Expenses improved to $7.4 million in Q4 2025 per RCEL's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $7.4 million in Q4 2025 and bottomed at -$4.8 million in Q2 2025.
• Historically, Change in Accured Expenses has averaged $321647.1 across 5 years, with a median of $427000.0 in 2023.
• The widest YoY moves for Change in Accured Expenses: up 996.44% in 2025, down 730.21% in 2025.
• Over 5 years, Change in Accured Expenses stood at -$655000.0 in 2021, then soared by 697.56% to $3.9 million in 2022, then tumbled by 72.48% to $1.1 million in 2023, then sank by 37.33% to $675000.0 in 2024, then jumped by 996.44% to $7.4 million in 2025.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $7.4 million, -$2.1 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.